Therapeutic application of regeneration-associated cells: a novel

Chronic diseases with comorbidities or associated risk factors may impair the function of regenerative cells and the regenerative microenvironment. Following this consideration, the vasculogenic conditioning culture (VCC) method was developed to boost the regenerative microenvironment to achieve regeneration-associated cells (RACs), which contain vasculogenic endothelial progenitor cells (EPCs) and anti-inflammatory/anti-immunity cells. Preclinical and clinical studies demonstrate that RAC transplantation is a safe and convenient cell population for promoting ischemic tissue recovery based on its strong vasculogenicity and functionality. The outputs of the scientific reports reviewed in the present study shed light on the fact that RAC transplantation is efficient in curing various diseases. Here, we compactly highlight the universal features of RACs and the latest progress in their translation toward clinics.

Therapeutic application of regeneration-associated cells: a novel

PDF) Therapeutic application of regeneration-associated cells: a

Summary of our study.

Mesenchymal stem cells: environmentally responsive therapeutics

Mesenchymal stem cells: environmentally responsive therapeutics

The three-compartment model of EPC kinetics. a According to

Hypothetic interaction between ECFCs and T cells. a This schematic

PDF) Contemporary Challenges of Regenerative Therapy in Patients

Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat

SDF1 gradient associates with the distribution of c-Kit+ cardiac cells